Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Autoimmune anti-DNA antibodies predict disease severity in COVID-19 patients

Claudia Gomes, Marisol Zuniga, Kelly A. Crotty, Kun Qian, Lawrence Hsu Lin, Kimon V. Argyropoulos, Huilin Li, Paolo Cotzia, View ORCID ProfileAna Rodriguez
doi: https://doi.org/10.1101/2021.01.04.20249054
Claudia Gomes
1Department of Microbiology, New York University Grossman School of Medicine, 550 First Ave. New York, NY-10016, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marisol Zuniga
1Department of Microbiology, New York University Grossman School of Medicine, 550 First Ave. New York, NY-10016, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly A. Crotty
1Department of Microbiology, New York University Grossman School of Medicine, 550 First Ave. New York, NY-10016, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kun Qian
2Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, 550 First Ave. New York, NY-10016, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence Hsu Lin
3Department of Pathology, New York University Grossman School of Medicine, 550 First Ave. New York, NY-10016, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimon V. Argyropoulos
3Department of Pathology, New York University Grossman School of Medicine, 550 First Ave. New York, NY-10016, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huilin Li
2Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, 550 First Ave. New York, NY-10016, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paolo Cotzia
3Department of Pathology, New York University Grossman School of Medicine, 550 First Ave. New York, NY-10016, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Rodriguez
1Department of Microbiology, New York University Grossman School of Medicine, 550 First Ave. New York, NY-10016, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ana Rodriguez
  • For correspondence: ana.rodriguez{at}nyumc.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

COVID-19 can lead to severe disease and death, however the mechanisms of pathogenesis in these patients remain poorly understood. High levels of autoimmune antibodies have been observed frequently in COVID-19 patients but their specific contribution to disease severity and clinical manifestations remain unknown.

We performed a retrospective study of 115 COVID-19 hospitalized patients with different degrees of severity to analyze the generation of autoimmune antibodies to common antigens: a lysate of erythrocytes, the lipid phosphatidylserine (PS) and DNA.

High levels of IgG autoantibodies against erythrocyte lysates were observed in a large percentage (up to 41%) of patients. Anti-DNA antibodies determined upon hospital admission correlated strongly with later development of severe disease, showing a positive predictive value of 89.5% and accounting for 22% of total severe cases. Statistical analysis identified strong correlations between anti-DNA antibodies and markers of cell injury, coagulation, neutrophil levels and erythrocyte size.

Anti-DNA autoantibodies may play an important role in the pathogenesis of COVID-19 and could be developed as a predictive biomarker for disease severity and specific clinical manifestations.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was supported by the NYU Langone COVID-19 special fund. The funder had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The collection of COVID-19 human biospecimens for research has been approved by NYULH Institutional Review Board under the S16-00122 Universal Mechanism of human bio-specimen collection and storage for research. This protocol allows the collection and analysis of clinical and demographic data. The database used for this project is de-identified.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data referred to in the manuscript is available in the provided supplementary tables

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 04, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Autoimmune anti-DNA antibodies predict disease severity in COVID-19 patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Autoimmune anti-DNA antibodies predict disease severity in COVID-19 patients
Claudia Gomes, Marisol Zuniga, Kelly A. Crotty, Kun Qian, Lawrence Hsu Lin, Kimon V. Argyropoulos, Huilin Li, Paolo Cotzia, Ana Rodriguez
medRxiv 2021.01.04.20249054; doi: https://doi.org/10.1101/2021.01.04.20249054
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Autoimmune anti-DNA antibodies predict disease severity in COVID-19 patients
Claudia Gomes, Marisol Zuniga, Kelly A. Crotty, Kun Qian, Lawrence Hsu Lin, Kimon V. Argyropoulos, Huilin Li, Paolo Cotzia, Ana Rodriguez
medRxiv 2021.01.04.20249054; doi: https://doi.org/10.1101/2021.01.04.20249054

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)